- Home
- GRX vs HUMA Comparison
GRX vs HUMA Comparison
Compare GRX & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GRX | HUMA |
|---|---|---|
| Founded | N/A | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.5M | 165.7M |
| IPO Year | 2007 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GRX | HUMA |
|---|---|---|
| Price | $9.99 | $0.42 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $1.63 |
| AVG Volume (30 Days) | 12.2K | ★ 5.7M |
| Earning Date | 01-01-0001 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 79.37 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,038,000.00 |
| Revenue This Year | N/A | $72.32 |
| Revenue Next Year | N/A | $518.79 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.80 | $0.34 |
| 52 Week High | $10.20 | $1.78 |
Technical Indicators
Market Signals| Indicator | GRX | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 60.44 | 37.68 |
| Support Level | $9.59 | $0.34 |
| Resistance Level | $10.05 | $0.46 |
| Average True Range (ATR) | 0.11 | 0.04 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 74.77 | 45.00 |
Price Performance
Historical ComparisonAbout GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
About HUMA Humacyte Inc.
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.